|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Pathophysiology |
Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study
1 Addenbrooke’s Hospital, Cambridge University Medical School, Cambridge, U.K
2 University Department of Pathological Biochemistry, Glasgow Royal Infirmary, Glasgow, U.K
3 Department of Medicine #7873, University of Texas Health Science Center at San Antonio, San Antonio, Texas
4 Center de Estudios in Diabetes, Mexico City, Mexico
5 Department of Human Nutrition, Glasgow Royal Infirmary, Glasgow, U.K
OBJECTIVE—Recent evidence suggests that C-reactive protein (CRP) may predict development of diabetes in Caucasian populations. We evaluated CRP as a possible risk factor of the development of diabetes and metabolic syndrome in a 6-year study of 515 men and 729 women from the Mexico City Diabetes Study.
RESEARCH DESIGN AND METHODS—Baseline CRP, indexes of adiposity, and insulin resistance (homeostasis model assessment [HOMA-IR]) were used to predict development of the metabolic syndrome, defined as including two or more of the following: 1) dyslipidemia (triglyceride 
2.26 mmol/l or HDL cholesterol 
0.91 mmol/l in men and 1.17 mmol/l in women; <35 and 40 mg/dl for men and women); 2) hypertension (blood pressure >140/90 mmHg or on hypertensive medication); or 3) diabetes (1999 World Health Organization criteria).
RESULTS—At baseline, CRP correlated significantly (P < 0.001) with all metabolic indexes in women, but less so in men. After 6 years, 14.2% of men and 16.0% of women developed the metabolic syndrome. Compared with tertile 1, women with CRP in the highest tertile had an increased relative risk of developing the metabolic syndrome by 4.0 (95% CI 2.0–7.9) and diabetes by 5.5 (2.2–13.5); these risks changed minimally after adjusting for BMI or HOMA-IR. The area under receiver-operating characteristic (ROC) curve for the prediction of the development of the syndrome was 0.684 for CRP, increasing to 0.706 when combined with BMI and to 0.710 for a complex model of CRP, BMI, and HOMA-IR.
CONCLUSIONS—CRP was not a significant predictor of the development of the metabolic syndrome in men. Our data strongly support the notion that inflammation is important in the pathogenesis of diabetes and metabolic disorders in women.
Abbreviations: CRP, C-reactive protein • HOMA-IR, homeostasis model assessment of insulin resistance • ROC, receiver-operating characteristic
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Soriano-Guillen, B. Hernandez-Garcia, J. Pita, N. Dominguez-Garrido, G. Del Rio-Camacho, and A. Rovira High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur. J. Endocrinol., July 1, 2008; 159(1): R1 - R4. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Qi, Z. Yu, X. Ye, F. Zhao, P. Huang, F. B. Hu, O. H. Franco, J. Wang, H. Li, Y. Liu, et al. Elevated Retinol-Binding Protein 4 Levels Are Associated with Metabolic Syndrome in Chinese People J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4827 - 4834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Andre, B. Balkau, S. Vol, M. A. Charles, E. Eschwege, and on behalf of the DESIR Study Group {gamma}-Glutamyltransferase Activity and Development of the Metabolic Syndrome (International Diabetes Federation Definition) in Middle-Aged Men and Women: Data From the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort Diabetes Care, September 1, 2007; 30(9): 2355 - 2361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liu, L. Tinker, Y. Song, N. Rifai, D. E. Bonds, N. R. Cook, G. Heiss, B. V. Howard, G. S. Hotamisligil, F. B. Hu, et al. A Prospective Study of Inflammatory Cytokines and Diabetes Mellitus in a Multiethnic Cohort of Postmenopausal Women Arch Intern Med, August 13, 2007; 167(15): 1676 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lorenzo, M. Serrano-Rios, M. T. Martinez-Larrad, C. Gonzalez-Villalpando, J. L. Gonzalez-Sanchez, M. J. Martinez-Calatrava, R. Gabriel, and S. M. Haffner Is Waist Circumference an Essential Component of the Metabolic Syndrome? Diabetes Care, August 1, 2007; 30(8): 2141 - 2142. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kallio, M. Kolehmainen, D. E Laaksonen, J. Kekalainen, T. Salopuro, K. Sivenius, L. Pulkkinen, H. M Mykkanen, L. Niskanen, M. Uusitupa, et al. Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1417 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Ye, Z. Yu, H. Li, O. H. Franco, Y. Liu, and X. Lin Distributions of C-Reactive Protein and its Association With Metabolic Syndrome in Middle-Aged and Older Chinese People J. Am. Coll. Cardiol., May 1, 2007; 49(17): 1798 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Thorand, J. Baumert, H. Kolb, C. Meisinger, L. Chambless, W. Koenig, and C. Herder Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002 Diabetes Care, April 1, 2007; 30(4): 854 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dehghan, I. Kardys, M. P.M. de Maat, A. G. Uitterlinden, E. J.G. Sijbrands, A. H. Bootsma, T. Stijnen, A. Hofman, M. T. Schram, and J. C.M. Witteman Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes Diabetes, March 1, 2007; 56(3): 872 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Capuzzi and J. S. Freeman C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge Clin. Diabetes, January 1, 2007; 25(1): 16 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-E. Paradis, K. O. Badellino, D. J. Rader, Y. Deshaies, P. Couture, W. R. Archer, N. Bergeron, and B. Lamarche Endothelial lipase is associated with inflammation in humans J. Lipid Res., December 1, 2006; 47(12): 2808 - 2813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. ALEXANDRAKI, C. PIPERI, C. KALOFOUTIS, J. SINGH, A. ALAVERAS, and A. KALOFOUTIS Inflammatory Process in Type 2 Diabetes: The Role of Cytokines Ann. N.Y. Acad. Sci., November 1, 2006; 1084(1): 89 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Melamed, A. Shirom, S. Toker, and I. Shapira Burnout and Risk of Type 2 Diabetes: A Prospective Study of Apparently Healthy Employed Persons Psychosom Med, November 1, 2006; 68(6): 863 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Aguilar-Salinas, R. Rojas, C. Gonzalez-Villalpando, F. J. Gomez-Perez, R. Mehta, G. Olaiz, J. A. Rull, and D. R. Cox Design and validation of a population-based definition of the metabolic syndrome. Diabetes Care, November 1, 2006; 29(11): 2420 - 2426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Libby and P. M. Ridker Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A33 - A46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Englund Ogge, G. Brohall, C. J. Behre, C. Schmidt, and B. Fagerberg Alcohol Consumption in Relation to Metabolic Regulation, Inflammation, and Adiponectin in 64-Year-Old Caucasian Women: A population-based study with a focus on impaired glucose regulation Diabetes Care, April 1, 2006; 29(4): 908 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hassinen, T. A. Lakka, P. Komulainen, H. Gylling, A. Nissinen, and R. Rauramaa C-Reactive Protein and Metabolic Syndrome in Elderly Women: A 12-year follow-up study Diabetes Care, April 1, 2006; 29(4): 931 - 932. [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, K. Williams, A. Festa, L. E. Wagenknecht, R. B. D'Agostino Jr, and S. M. Haffner Liver Markers and Development of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Diabetes, November 1, 2005; 54(11): 3140 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Doi, Y. Kiyohara, M. Kubo, T. Ninomiya, Y. Wakugawa, K. Yonemoto, M. Iwase, and M. Iida Elevated C-Reactive Protein Is a Predictor of the Development of Diabetes in a General Japanese Population: The Hisayama Study Diabetes Care, October 1, 2005; 28(10): 2497 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Brantsma, S. J.L. Bakker, H. L. Hillege, D. de Zeeuw, P. E. de Jong, R. T. Gansevoort, and the PREVEND Study Group Urinary Albumin Excretion and Its Relation With C-Reactive Protein and the Metabolic Syndrome in the Prediction of Type 2 Diabetes Diabetes Care, October 1, 2005; 28(10): 2525 - 2530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Thorand, H. Kolb, J. Baumert, W. Koenig, L. Chambless, C. Meisinger, T. Illig, S. Martin, and C. Herder Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes: Results From the MONICA/KORA Augsburg Study, 1984-2002 Diabetes, October 1, 2005; 54(10): 2932 - 2938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Clearfield C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular Disease J Am Osteopath Assoc, September 1, 2005; 105(9): 409 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. LaMonte, C. E. Barlow, R. Jurca, J. B. Kampert, T. S. Church, and S. N. Blair Cardiorespiratory Fitness Is Inversely Associated With the Incidence of Metabolic Syndrome: A Prospective Study of Men and Women Circulation, July 26, 2005; 112(4): 505 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.A. Lteif, K. Han, and K.J. Mather Obesity, Insulin Resistance, and the Metabolic Syndrome: Determinants of Endothelial Dysfunction in Whites and Blacks Circulation, July 5, 2005; 112(1): 32 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Moran, L. M. Steffen, D. R. Jacobs Jr., J. Steinberger, J. S. Pankow, C.-P. Hong, R. P. Tracy, and A. R. Sinaiko Relation of C-Reactive Protein to Insulin Resistance and Cardiovascular Risk Factors in Youth Diabetes Care, July 1, 2005; 28(7): 1763 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H. C.A. Emsley, S. Forconi, S. J. Hopkins, L. Masotti, et al. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members Stroke, June 1, 2005; 36(6): 1316 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tomiyama, Y. Koji, M. Yambe, K. Motobe, K. Shiina, Z. Gulnisa, Y. Yamamoto, and A. Yamashina Elevated C-Reactive Protein Augments Increased Arterial Stiffness in Subjects With the Metabolic Syndrome Hypertension, May 1, 2005; 45(5): 997 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Orchard, M. Temprosa, R. Goldberg, S. Haffner, R. Ratner, S. Marcovina, S. Fowler, and for the Diabetes Prevention Program Research Group The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial Ann Intern Med, April 19, 2005; 142(8): 611 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. W. Petersen and B. K. Pedersen The anti-inflammatory effect of exercise J Appl Physiol, April 1, 2005; 98(4): 1154 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Tataranni and E. Ortega A Burning Question: Does an Adipokine-Induced Activation of the Immune System Mediate the Effect of Overnutrition on Type 2 Diabetes? Diabetes, April 1, 2005; 54(4): 917 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Engstrom, B. Hedblad, K.-F. Eriksson, L. Janzon, and F. Lindgarde Complement C3 Is a Risk Factor for the Development of Diabetes: A Population-Based Cohort Study Diabetes, February 1, 2005; 54(2): 570 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Recasens, A. Lopez-Bermejo, W. Ricart, J. Vendrell, R. Casamitjana, and J. M. Fernandez-Real An Inflammation Score Is Better Associated with Basal than Stimulated Surrogate Indexes of Insulin Resistance J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 112 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Juutilainen, S. Kortelainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk Diabetes Care, December 1, 2004; 27(12): 2898 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Ford and D. M. Mannino Prospective Association Between Lung Function and the Incidence of Diabetes: Findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study Diabetes Care, December 1, 2004; 27(12): 2966 - 2970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Daskalopoulou, D. P. Mikhailidis, and M. Elisaf Prevention and Treatment of the Metabolic Syndrome Angiology, November 1, 2004; 55(6): 589 - 612. [Abstract] [PDF]
|
|
|
|
|
|
S. S. Daskalopoulou, D. P. Mikhailidis, and M. Elisaf Prevention and Treatment of the Metabolic Syndrome Angiology, November 1, 2004; 55(6): 589 - 612. [Abstract] [PDF]
|
|
|
|
|
|
K. Kaushal, A. H. Heald, K. W. Siddals, M. S. Sandhu, D. B. Dunger, J. M. Gibson, and N. J. Wareham The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome Diabetes Care, November 1, 2004; 27(11): 2682 - 2688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Esposito, R. Marfella, M. Ciotola, C. Di Palo, F. Giugliano, G. Giugliano, M. D'Armiento, F. D'Andrea, and D. Giugliano Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome: A Randomized Trial JAMA, September 22, 2004; 292(12): 1440 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Caballero, A. Delgado, C. A. Aguilar-Salinas, A. N. Herrera, J. L. Castillo, T. Cabrera, F. J. Gomez-Perez, and J. A. Rull The Differential Effects of Metformin on Markers of Endothelial Activation and Inflammation in Subjects with Impaired Glucose Tolerance: A Placebo-Controlled, Randomized Clinical Trial J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3943 - 3948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Kriketos, J. R. Greenfield, P. W. Peake, S. M. Furler, G. S. Denyer, J. A. Charlesworth, and L. V. Campbell Inflammation, Insulin Resistance, and Adiposity: A study of first-degree relatives of type 2 diabetic subjects Diabetes Care, August 1, 2004; 27(8): 2033 - 2040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Rutter, J. B. Meigs, L. M. Sullivan, R. B. D'Agostino Sr, and P. W.F. Wilson C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study Circulation, July 27, 2004; 110(4): 380 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Winer and J. R. Sowers Epidemiology of Diabetes J. Clin. Pharmacol., April 1, 2004; 44(4): 397 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Wannamethee Anti-Inflammatory Action of Alcohol and Risk of Type 2 Diabetes Mellitus--Reply Arch Intern Med, March 8, 2004; 164(5): 572 - 573. [Full Text] [PDF]
|
|
|
|
|
|
J. C. Pickup Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes Diabetes Care, March 1, 2004; 27(3): 813 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. B. Hu, J. B. Meigs, T. Y. Li, N. Rifai, and J. E. Manson Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women Diabetes, March 1, 2004; 53(3): 693 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Kip, O. C. Marroquin, D. E. Kelley, B. D. Johnson, S. F. Kelsey, L. J. Shaw, W. J. Rogers, and S. E. Reis Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report From the Women's Ischemia Syndrome Evaluation (WISE) Study Circulation, February 17, 2004; 109(6): 706 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schillinger, M. Exner, J. Amighi, W. Mlekusch, S. Sabeti, H. Rumpold, O. Wagner, and E. Minar Joint Effects of C-Reactive Protein and Glycated Hemoglobin in Predicting Future Cardiovascular Events of Patients With Advanced Atherosclerosis Circulation, November 11, 2003; 108(19): 2323 - 2328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Festa, A. J.G. Hanley, R. P. Tracy, R. D'Agostino Jr, and S. M. Haffner Inflammation in the Prediabetic State Is Related to Increased Insulin Resistance Rather Than Decreased Insulin Secretion Circulation, October 14, 2003; 108(15): 1822 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nakanishi, K. Yamane, N. Kamei, M. Okubo, and N. Kohno Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans Diabetes Care, October 1, 2003; 26(10): 2754 - 2757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Hunt, K. Williams, D. Rivera, D. H. O'Leary, S. M. Haffner, M. P. Stern, and C. Gonzalez Villalpando Elevated Carotid Artery Intima-Media Thickness Levels in Individuals Who Subsequently Develop Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1845 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Satoh, Y. Ogawa, T. Usui, T. Tagami, S. Kono, H. Uesugi, H. Sugiyama, A. Sugawara, K. Yamada, A. Shimatsu, et al. Antiatherogenic Effect of Pioglitazone in Type 2 Diabetic Patients Irrespective of the Responsiveness to Its Antidiabetic Effect Diabetes Care, September 1, 2003; 26(9): 2493 - 2499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C.B. Tan, N. M.S. Wat, S. C.F. Tam, E. D. Janus, T.H. Lam, and K. S.L. Lam C-Reactive Protein Predicts the Deterioration of Glycemia in Chinese Subjects With Impaired Glucose Tolerance Diabetes Care, August 1, 2003; 26(8): 2323 - 2328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Grundy Inflammation, Metabolic Syndrome, and Diet Responsiveness Circulation, July 15, 2003; 108(2): 126 - 128. [Full Text] [PDF]
|
|
|
|
|
|
B. B. Duncan, M. I. Schmidt, J. S. Pankow, C. M. Ballantyne, D. Couper, A. Vigo, R. Hoogeveen, A. R. Folsom, and G. Heiss Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study Diabetes, July 1, 2003; 52(7): 1799 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 |